Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy.
about
Imaging in Endovascular Stroke TrialsStroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices.Advanced imaging to extend the therapeutic time window of acute ischemic stroke.A benchmarking tool to evaluate computer tomography perfusion infarct core predictions against a DWI standard.Perfusion patterns of ischemic stroke on computed tomography perfusion.Clinical predictors and management of hemorrhagic transformation.Imaging predictors of outcome following intravenous thrombolysis in acute stroke.Optimal Computed Tomographic Perfusion Scan Duration for Assessment of Acute Stroke Lesion Volumes.Collaterals: an important determinant of prolonged ischemic penumbra versus rapid cerebral infarction?Ischemic core and hypoperfusion volumes predict infarct size in SWIFT PRIME.Computed Tomography Perfusion Alberta Stroke Program Early Computed Tomography Score Is Associated with Hemorrhagic Transformation after Acute Cardioembolic Stroke.Complete reversibility of a 'malignant profile' left MCA territory stroke.
P2860
Q28084967-18ED8D7C-2172-4D63-A732-71F9E6F91D2FQ30689276-1C50C0B5-BD1E-41D1-9096-8E2BBFF34785Q34573462-B736F0C6-086E-4014-B3D2-D34E0538540BQ35867654-197EC374-B76B-438D-9922-D8B557699051Q37382879-2628B8DA-5853-4019-B013-E57A509B8B34Q38074569-81C8D41E-AC00-4FD3-8095-D2C6D8A9A58BQ38172843-7C3C8F48-50BD-47A3-9CF3-64E0E565D9C9Q39147307-19F37FF2-58B7-488E-A05D-D0CEF256F343Q42943714-9B599FDA-6822-4DBE-9E3D-5815323685A4Q46871548-6401B4C1-39EC-419D-B1F9-554393F6B3A9Q47151913-00401D28-B383-4D1E-A1B7-CA5C559E4602Q48168932-5DD25CA4-7D2E-4A77-8D30-DAA63A7092EA
P2860
Patients with the malignant profile within 3 hours of symptom onset have very poor outcomes after intravenous tissue-type plasminogen activator therapy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Patients with the malignant pr ...... plasminogen activator therapy.
@ast
Patients with the malignant pr ...... plasminogen activator therapy.
@en
type
label
Patients with the malignant pr ...... plasminogen activator therapy.
@ast
Patients with the malignant pr ...... plasminogen activator therapy.
@en
prefLabel
Patients with the malignant pr ...... plasminogen activator therapy.
@ast
Patients with the malignant pr ...... plasminogen activator therapy.
@en
P2093
P2860
P1433
P1476
Patients with the malignant pr ...... plasminogen activator therapy.
@en
P2093
Greg Zaharchuk
Gregory W Albers
Maarten G Lansberg
Manabu Inoue
Matus Straka
Michael Mlynash
Roland Bammer
P2860
P304
P356
10.1161/STROKEAHA.112.653329
P407
P577
2012-07-17T00:00:00Z